TRINITY BIOSYSTEMS INC has a total of 38 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are MINERVAX APS, UNIV DEL QUINDIO and PROTOX THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | Canada | 7 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | Australia | 3 | |
#6 | China | 2 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Mrsny Randall J | 32 |
#2 | Zane Doris Tham | 4 |
#3 | Dean Deborah | 2 |
#4 | Mrsny Randall | 1 |
Publication | Filing date | Title |
---|---|---|
US2009092660A1 | Methods and compositions for needleless delivery of particles | |
US2009305978A1 | Methods for increasing the size of animals using needleless delivery constructs | |
CA2631981A1 | Methods and compositions for needleless delivery of binding partners | |
US2007141070A1 | Compositions for needleless delivery of antibodies | |
WO2006050420A2 | Chimeric immunogens that comprise ovalbumin | |
WO2006135428A2 | Methods and compositions for inducing an immune response against multiple antigens | |
CN101072584A | Methods and compositions for needleless delivery of macromolecules | |
EP1812054A2 | Methods and compositions for immunizing against pseudomonas infection | |
WO2006044205A2 | Methods and compositions for needleless delivery of macromolecules |